<DOC>
	<DOCNO>NCT02273960</DOCNO>
	<brief_summary>The purpose study assess safety tolerability BMS-986004 administer subject ITP .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy Adult Subjects With ITP</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com â‰¥18 year old , diagnosed persistent chronic ITP Secondary immune thrombocytopenia Drug induce thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>